MEN1 IS A MARKER AND THERAPEUTIC TARGET FOR BREAST AND PROSTATE CANCER

The present invention provides genomic markers for determining the presen ce or absence of breast cancer. The invention further demonstrates that inhi bition of MEN1 reduces breast or prostate cancer proliferation, thereby demo nstrating that inhibition of MEN1 activity or expression can be used to...

Full description

Saved in:
Bibliographic Details
Main Authors PARIS, PAMELA L, COLLINS, COLIN C
Format Patent
LanguageEnglish
French
Published 15.11.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention provides genomic markers for determining the presen ce or absence of breast cancer. The invention further demonstrates that inhi bition of MEN1 reduces breast or prostate cancer proliferation, thereby demo nstrating that inhibition of MEN1 activity or expression can be used to redu ce breast cancer or prostate cancer proliferation in an individual in need t hereof.
Bibliography:Application Number: CA20072656824